Search PubMed⌕ Search

Biomedical subjects

P Lefebvre

Publications and source records attributed to P Lefebvre.

At least 181 records · Page 10Linked to original sources

RNA binding to the untransformed glucocorticoid receptor. Sensitivity to substrate-specific ribonucleases and characterization of a ribonucleic acid associated with the purified receptor.

The cytosolic untransformed molybdate-stabilized glucocorticoid-receptor complex from rat liver was eluted as a heterogenous peak containing two components with Stokes radii (Rs) of 8.3 nm and 7.1 nm when analyzed by size-exclusion HPLC even in the absence of molybdate. In contrast, the highly purified glucocorticoid receptor yielded a sharp symmetrical peak of Rs = 7.1 nm. We demonstrate that the 7.1-nm component could not result from a proteolytic degradation of the 8.3-nm receptor form. The same receptor heterogeneity was observed in thymus cytosol which contains less proteases than liver. After labeling with [3H]dexamethasone 21-mesylate and SDS/PAGE the same 94-kDa receptor band was revealed in both the 8.3-nm and 7.1-nm forms. Immunoblotting experiments showed that both the 94-kDa hormone-binding subunit and the 90-kDa heat-shock protein were present in the two different receptor forms. The 8.3-nm receptor form was converted to the 7.1-nm receptor form after treatment by ribonuclease A in the presence of molybdate and this effect was dose-dependent, being completely prevented by placental ribonuclease inhibitor (RNasin). In contrast, in the presence of molybdate, the 7.1-nm receptor form was ribonuclease-insensitive. Treatment of cytosol with RNase A in the absence of molybdate, partially shifted the untransformed receptor towards the 5.2-nm transformed receptor form. This effect was abolished by placental ribonuclease inhibitor. RNase S protein, an enzymatically inactive proteolytic fragment of RNase A, or S1 nuclease, which is specific for single-stranded nucleic acids, were ineffective when used instead of RNase A. In contrast, cobra venom endonuclease, which preferentially attacks double-stranded regions of small RNAs, caused a complete conversion of the 7-8-nm untransformed receptor to the 5.2-nm transformed receptor form. These results were not observed in the presence of molybdate. Addition of RNasin prior to heating cytosol in the absence of molybdate did not prevent the receptor from dissociating to the 5.2-nm form, suggesting that an endogenous RNase is not involved in the transformation process. The 7.1-nm receptor form was shifted to a 9.2-nm complex when incubated with an excess of GR 49 antireceptor antibody, whereas the 8.3-nm receptor form did not bind to the antibody.(ABSTRACT TRUNCATED AT 400 WORDS)

Animals↗

RU 486 stabilizes a high molecular weight form of the glucocorticoid receptor containing the 90K non-steroid binding protein in intact thymus cells.

The interaction with the glucocorticoid receptor of RU 486, a recently described antiglucocorticoid, was investigated in intact cells. When incubated at 37 degrees C with intact rat thymocytes [3H] RU 486 underwent negligible nuclear transfer. Moreover when assayed in physiological buffers, i.e. physiological ionic strength and absence of molybdate, the cytosolic [3H] RU 486-receptor complexes obtained displayed a 7-8 nm Stokes radius after analysis by high performance size exclusion chromatography (HPSEC). These high size complexes appeared stable in the native cytosol but dissociated during sucrose gradient centrifugation. Western blot analysis of the fractions obtained after HPSEC separation was performed using a monoclonal antibody able to recognize the 90K non steroid binding protein associated with the molybdate stabilized glucocorticoid receptor complexes. This antibody clearly demonstrated the presence of a 90K non-steroid binding protein in the 7-8 nm peak obtained with [3H] RU 486 receptor complexes. On the contrary [3H] triamcinolone acetonide in the same conditions yielded a 5 nm peak of transformed receptor which did not contain the 90K protein. Thus RU 486, in absence of molybdate, stabilized the 90K protein-receptor interaction in intact cells, an event probably related to its antiglucocorticoid activity.

Animals↗

RU 486 stabilizes the glucocorticoid receptor in a non-transformed high molecular weight form in intact thymus cells under physiological conditions.

When incubated at 37 degrees C for 1 h with intact rat thymocytes [3H]RU 486 underwent only partial nuclear transfer since more than 65% of the receptor bound radioactivity was still cytosolic (versus less than 10% for [3H]triamcinolone acetonide). Moreover when prepared and assayed in physiological buffers, i.e. physiological ionic strength and absence of molybdate, the cytosolic [3H]RU 486-receptor complex displayed a 7-8 nm Stokes radius after analysis by high performance size exclusion chromatography. This high size complex appeared stable for more than 24 h in the native cytosol. However its apparent sedimentation constant was 4S after sucrose gradient centrifugation for 16 h in the same buffer. These results suggested that RU 486 stabilizes a high molecular weight form of the receptor in intact cells and that this form dissociates during sucrose gradient analysis. The conditions of this in vitro dissociation were examined and compared with the results of a kinetic study of the nuclear transfer of [3H]RU 486. [3H]Triamcinolone acetonide was used as reference glucocorticoid agonist.

Animals↗

Concentration of bone marrow progenitor cells by separation on a Percoll gradient using the Haemonetics model 30.

To perform an optimal ex vivo bone marrow purge, it is necessary to concentrate the bone marrow progenitor cells and to eliminate both the red blood cells and the polymorphonuclear leucocytes. To achieve this goal which cannot be accomplished by using the Haemonetics model 30 alone, we used the Haemonetics model 30 and a density gradient together in a two-step procedure. In the first step we obtained the buffy coat from original bone marrow grafts and in the second we reintroduced these buffy coats into the Haemonetics bowl followed by Percoll, adjusted to 1.079 g/ml, at 5 ml/min in order to recover the light density mononuclear cells. After this second step, the mean volume of the marrow and the RBC and nucleated cell contaminations were reduced to 9%, 0.96% and 16% of their original values the unseparated bone marrow, respectively. This was far better than the values obtained after the first step (volume: 19%; RBC: 10%; nucleated cells: 54%). The CFU-GM recoveries after the first and second steps were 71% and 70% of the original samples, respectively. The entire procedure lasted between 75 and 150 min. At this time, 17 of the 24 patients whose bone marrow was separated using Percoll gradient in the Haemonetics bowl have been grafted. Thirteen of these 17 patients had an evaluable haematological recovery which was complete and rapid for all but one patient with acute myeloid leukaemia. These results demonstrate that the introduction of a density gradient into the Haemonetics model 30 bowl is possible and effective. The reduction in total volume and cell number permits ex vivo purging, without decreasing the grafting capability.

Bone Marrow↗

The psychoanalysis of a patient with ulcerative colitis. The impact of fantasy, affect, and the intensity of drives on the outcome of treatment.

In this paper the clinical case of a patient with ulcerative colitis is described, to illustrate how the vicissitudes of affects and fantasies, and the intensity of drives can set limits to the capacity for change in psychoanalysis. Drive intensity at all zonal levels is discussed. The author describes two unconscious fantasies which fuelled the resistance to progress, because of their inevitable links with traumatic and disavowed affects, and with libidinal and aggressive drives. The first fantasy described is that of the narcissistic impasse, in which the patient could not orchestrate an optimal distance with the object, who always seemed too perilously near or far. The second fantasy, giving rise to the first, is that of the Faustian bargain, according to which the patient repeated an infantile disposition to effect a trade-off with a needed but elusive ideal object, resulting in pathological splitting, a loss of a sense of ownership of the Psyche and the Soma, and eventual somatic vulnerability.

Adult↗

Improved Stokes radius measurement of the glucocorticoid receptor using TSK G4000SW and TSK G3000SW high-performance size-exclusion columns. Analytical and preparative applications.

The Stokes radius of the rat liver glucocorticoid receptor was determined using TSK G3000SW and TSK G4000SW high-performance size-exclusion columns. The accuracy of the calibration graph for proteins larger than 6 nm on the TSK G4000SW column allowed the resolution of a heterogeneous structure for the cytosolic untransformed receptor, giving two forms with Rs values of 8.3 and 7.1 nm, whereas the transformed receptor elutes with an Rs value of 4.7-5.3 nm. The 8.3 nm form was not observed for the highly purified untransformed receptor. Parallel analyses of the cytosolic untransformed receptor on conventional gravity-fed Bio-Gel A 1.5-m or Ultrogel AcA-22 size-exclusion columns could not resolve two components. The resolution efficiencies of high-performance size-exclusion chromatography and open-column size-exclusion chromatography were compared. Further, owing to its rapidity, high-performance chromatography allowed the characterization of steroid-receptor complexes having half-lives as short as 90 min and very unstable receptor forms could be detected. Specific applications are considered, such as the resort to a small TSK GSWP guard column for the rapid separation of affinity-purified [3H]TA-receptor complexes from free eluting steroid, and to a preparative TSK G4000SW column for the fractionation of significant amounts of the two untransformed receptor forms.

Animals↗

[Not Available].

Explore the source record for details and available documents.

France↗

[Not Available].

Explore the source record for details and available documents.

France↗

Physical characterization of the activated and non-activated forms of the glucocorticoid-receptor complex bound to the steroid antagonist [3H]RU 486.

We have compared the physicochemical characteristics of the non-activated (molybdate stabilized) glucocorticoid-receptor complex bound either to [3H]triamcinolone acetonide or to the antagonist [3H]RU 486 with those of the activated (25 degrees C preheated) complexes. The level of activation was measured by a DNA cellulose assay. The physicochemical features of the steroid-receptor complexes were analyzed by various techniques including high-performance size exclusion chromatography, sucrose gradient sedimentation and high-performance DEAE ion exchange chromatography. All the buffers used during the analytical procedures contained sodium molybdate in order to prevent any dissociation of the steroid-receptor complex. The non-activated glucocorticoid receptor bound either to [3H]TA or to [3H]RU 486 sedimented at 9.3S on sucrose gradient, displayed at 70 A Stokes radius in high performance size exclusion chromatography on TSK G4000 SW column, and was eluted at 0.22-0.28 M KCl by anion-exchange chromatography on a DEAE 545 column. After activation the Stokes radius and the sedimentation coefficient declined to 50 A and 4.5S respectively, and the complex was eluted by 0.10-0.12 M KCl on the ion-exchange column. No qualitative difference could be detected between the characteristics of the glucocorticoid-receptor complexes bound either to [3H]TA or to [3H]RU 486. Moreover, the relative distribution of "non-activated" and "activated" forms of the glucocorticoid receptor obtained through physicochemical experiments was highly correlated with the activation level determined by DNA binding experiments. However the activation level of [3H]RU 486-glucocorticoid-receptor complex appeared markedly decreased (15%) when compared with that of the agonist [3H]TA-receptor complex (65%). Experiments done with an antagonist steroid of the 17 beta-carboxamide series of dexamethasone exhibit the same results with an activation level of 12% as compared with triamcinolone acetonide. Thus, two antihormones which have different structures show the same behavior towards the glucocorticoid-receptor complex by strikingly reducing both the activation process and the size reduction of the steroid-receptor complex which is concomitant to activation and which could constitute the first step of this process.

Animals↗